Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jiyeon, Lee, Heetae, An, Jinho, Song, Youngcheon, Lee, Chong-Kil, Kim, Kyungjae, Kong, Hyunseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736992/
https://www.ncbi.nlm.nih.gov/pubmed/31551944
http://dx.doi.org/10.3389/fmicb.2019.01947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736992/
https://www.ncbi.nlm.nih.gov/pubmed/31551944
http://dx.doi.org/10.3389/fmicb.2019.01947

Ejemplares similares